Large Zealand shareholder considers investing in Orphazyme
Dutch family foundation Van Herk, which owns a fifth of shares in Zealand Pharma, is considering buying shares in another Danish biotech company: Orphazyme.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.
Try us for 14 days
Try a trial subscription for access to our quality journalism